ADT 2011 Annual Report Download - page 29

Japan, and as a member of the Board of Directors of the International Institute for the Study of Cross-
Border M&A, an international joint venture to promote the high-level study and analysis of cross-border
mergers, acquisitions and strategic investments, and the Business Roundtable. Mr. Paliwal served on the
board for Embarq Corporation until its merger with CenturyTel. He has served previously as Chairman of
ABB India Ltd., a publicly listed company in India and as Chairman of the US National Foreign Trade
Council in Washington, DC. He has served as a Director for the US China Business Council, the US India
Business Council, and the International Swimming Hall of Fame. He also served for three years as
Economic Advisor to the Governor of Guangdong Province, China. Mr. Paliwal’s qualifications to serve on
the board include his extensive leadership and governance experience as a public company chief executive
officer, his engineering and financial background, and his extensive global experience, especially in emerging
markets important to the Company.
William S. Stavropoulos—Dr. Stavropoulos, age 72, joined our Board in March 2007.
Dr. Stavropoulos was the Chairman, President and Chief Executive Officer of Dow Chemical Company,
where his career spanned 39 years until his retirement in 2006. While at Dow, Dr. Stavropoulos served
in a variety of positions in research, marketing and general management. Dr. Stavropoulos graduated
from Fordham University with a B.S. in pharmaceutical chemistry and from the University of
Washington with a Ph.D. in medicinal chemistry. Dr. Stavropoulos serves as a director of Chemical
Financial Corporation, Teradata Corporation and Maersk, Inc., and is non-executive chairman of
Univar, Inc., a private company. He is a trustee to the Fidelity Group of Funds and the Rollin M.
Gerstacker Foundation, on the advisory boards of Maersk Corporation and Metalmark Capital LLC
and is an advisory partner of Clayton, Dubilier & Rice, LLC. Dr. Stavropoulos is also President and
Founder of the Michigan Baseball Foundation. Dr. Stavropoulos’ qualifications to serve on the board
include his extensive experience as an executive at Dow, his corporate governance experience gained
from his role as chairman and chief executive officer of Dow and as a director and advisor to other
publicly traded companies as well as his experience in the industrial sector.
Sandra S. Wijnberg—Ms. Wijnberg, age 55, joined our Board in March 2003. In March 2007,
Ms. Wijnberg was named Chief Administrative Officer of Aquiline Holdings LLC, a registered investment
advisor. From January 2000 to April 2006, Ms. Wijnberg was the Senior Vice President and Chief Financial
Officer at Marsh & McLennan Companies, Inc., a professional services firm with insurance and reinsurance
brokerage, consulting and investment management businesses. Before joining Marsh & McLennan
Companies, Inc. Ms. Wijnberg served as a Senior Vice President and Treasurer of Yum! Brands (previously
Tricon Global Restaurants, Inc.) and held various positions at PepsiCo, Inc., Morgan Stanley Group, Inc.
and American Express Company. Ms. Wijnberg is a graduate of the University of California, Los Angeles
and received an M.B.A. from the University of Southern California. Ms. Wijnberg also served on the board
of Tyco Electronics Ltd., a manufacturer of electronic parts and equipment, from 2007 to 2009.
Ms. Wijnberg is a director of Futurity First Financial Corporation, a private company in the insurance
business. Ms Wijnberg’s qualifications to serve on the board include her significant experience as an
executive in leadership positions in financial services companies and her financial acumen gained as the
chief financial officer of a publicly traded company.
R. David Yost—Mr. Yost, age 64, joined our Board in March 2009. Mr. Yost served as Director and
Chief Executive Officer of AmerisourceBergen, a comprehensive pharmaceutical services provider, from
August 2001 to June 30, 2011 when he retired. He was President of AmerisourceBergen from August 2001
to October 2002, Chairman and Chief Executive Officer of AmeriSource Health Corporation from
December 2000 to August 2001, and President and Chief Executive Officer of AmeriSource from May 1997
to December 2000. Mr. Yost also held a variety of other positions with AmeriSource Health Corporation
and its predecessors from 1974 to 1997. Mr. Yost is a graduate of the U.S. Air Force Academy and holds
an M.B.A. from the University of California, Los Angeles. Mr. Yost’s qualifications to serve on the board
include his extensive leadership and corporate governance experience gained as the chief executive and
director of a large publicly traded company in the pharmaceutical industry.
The Board unanimously recommends that shareholders vote FOR the election of all of the
nominees for Director to serve until the next Annual General Meeting.
2012 Proxy Statement 15